Showing articles associated with Adam Ritchie
Dr Adam Ritchie is an Immunologist, Lecturer in Human Science, and Senior Project Manager. He played a leading role in the development and successful roll-out of large-scale manufacturing of the Oxford-AstraZeneca COVID-19 vaccine, which has resulted in billions of doses being distributed across over 170 countries.
What is your main area(s) of interest/expertise?
My primary interest is in making sure that scientific knowledge has a positive impact on people’s lives, whether this is through the development of vaccines or at the interface of science with public policy. I am especially interested in the interaction between infectious agents and humans as host, and have done research on COVID-19, rabies, malaria, HIV, and prions.
Prior to joining the Jenner Institute, I was at the Blavatnik School of Government, training policy makers in science and public policy, including vaccine manufacturing and pandemic preparedness.
What are you working on right now?
I am currently running 3 main clinical trials, which involves designing them, making sure they are carried out safety and effectively, and immunological analysis of samples. These are the COV008 trial of intranasal administration of the Oxford-AstraZeneca COVID-19 vaccine, and two trials of our adenovirus-vectored vaccine against rabies.
I am also working on setting up the new BioProcess and Analytical Development (BiPAD) initiative, where we’ll be taking lessons learnt from getting the COVID-19 manufacturing process rolled out to getting medical breakthroughs from the academic lab to the clinic quickly, cheaply and with the greatest possible breadth of access.
Find out more about Adam and his work:
